Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 6;137(12):1615–1627. doi: 10.1182/blood.2020004918

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by The American Society of Hematology

PMC Copyright notice

Figure 7. — Expression of A20 and RNF138 in relationship to NF-κB activation in human lymphomas. (A) Representative images of IHC staining for RNF138, A20, and p-p65 Ser536 in lymphomas with and without MYD88^L265P. The images were taken from the same area for each target in individual lymphomas. Targets were stained with DAB as the chromogen (brown). The bar represents 10 μm. (B) Comparison of A20, RNF138, and p-p65 Ser536 expression between lymphomas with and without MYD88^L265P. (C) Correlation between the expression of A20 and RNF138 in lymphomas with and without MYD88^L265P. (D) Correlation between the expression of A20 and p-p65 Ser536 in lymphomas with and without MYD88^L265P. (E) Correlation between the expression of RNF138 and p-p65 Ser536 in lymphomas with and without MYD88^L265P. Pearson’s correlation coefficient tests provided the data in panels C-E. (F) The working model of MYD88, RNF138, and A20 in regulating physiological and oncogenic NF-κB activation. W, with; W/O, without.